Journal
NUTRITIONAL NEUROSCIENCE
Volume 26, Issue 7, Pages 594-604Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/1028415X.2022.2071809
Keywords
Caffeine; caffeine metabolites; urine; cognitive function; CERAD W-L; AFT; DSST; older adults; NHANES
Categories
Ask authors/readers for more resources
This study found a negative linear association between urinary caffeine and caffeine metabolite levels and cognitive decline in older adults. The effects were more evident in men.
Background: The effects of caffeine on cognitive impairment have not been conclusively determined. This study aimed to objectively assess the correlation between the urinary caffeine and caffeine metabolites and cognitive decline in older adults. Methods: Data on urinary caffeine and caffeine metabolites and the cognitive performance of participants aged 60 years and older were extracted from the National Health and Nutrition Examination Surveys 2011-2014. Binary logistic regression and restricted cubic splines (RCS) analyses were used to evaluate the association between urinary caffeine and caffeine metabolites and cognitive performance. Results: Eight hundred twenty-seven individuals were enrolled in this cross-sectional study. We observed that 1-methylxanthine, 3-methylxanthine, 7-methylxanthine, 1,3-dimethylxanthine, 1,7-dimethylxanthine, and 3,7-dimethylxanthine levels were significantly and inversely associated with cognitive decline. The RCS results suggested an approximately linear dose-response relationship between the aforementioned metabolites and cognitive performance. Moreover, the effects of urinary caffeine and caffeine metabolites on cognitive function assessed using the AFT were more evident in men. Conclusions: Our study suggested that urinary caffeine and caffeine metabolite levels were associated with a reduced risk of cognitive impairment in a linear manner, especially in men.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available